Responses
Oncolytic and local immunotherapy
Original research
RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
Compose a Response to This Article
Other responses
No responses have been published for this article.
